Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine hematopoietic progenitor cells for granulocytes and macrophages (GM-CFC)

Physiological Research

Volumn 54, Issue 2, 2005, Pages 207-213

  Hofer, M ^a   Vacek, A ^a   Weiterova L ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

GM CFC; Murine hematopoiesis; rHG CSF; rhGM CSF; rmGM CSF

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; RECOMBINANT MURINE GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; CELL PROLIFERATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; FEMALE; GRANULOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN;

ANIMALS; COLONY-STIMULATING FACTORS, RECOMBINANT; CYTOKINES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGES; MICE; MICE, INBRED ICR;

EID: 18844445613     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. AKIZAWA T, SHISHIDO K, KOSHIKAWA S: The effects and pharmacokinetics of rhG-CSF in patients with chronic renal failure. Artif Organs 19: 1251-1257, 1995.
2. CETINGUL N, KUTUKCULER N, KANTAR M, KAVAKLI K, NISLI G, GAGLAYAN S, OZTOP S: Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors. Turk J Pediat 39: 473-481, 1997.
3. DROUET M, MOURCIN F, GRENIER A, MAYOL JF, LEROUX V, SOTTO JJ, HERODIN F: Effect of ionizing radiation on hematopoietic stem cells and progenitor cells: role of apoptosis and potential therapeutic significance of antiapoptotic treatments. Can J Physiol Pharmacol 80: 700-709, 2002.
4. HERODIN F, BOURIN P, MAYOL JF, LATAILLADE JJ, DROUET M: Short-term injection of antiapoptotic cytokine combination soon after lethal gamma-irradiation promotes survival. Blood 101: 2609-2616, 2003.
5. HONKOOP AH, HOEKMAN K, WAGSTAFF J, VANGROENINGEN CJ, VERMORKEN JB, BOVEN E, PINEDO HM: Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously. Br J Cancer 74: 1132-1136, 1996.
6. KARASUYAMA H, MELCHERS F: Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2,3,4 or 5, using modified cDNA expression vectors. Eur J Immunol 18: 97-104, 1988.
7. LICHTMAN SM, RATAIN MJ, VAN ECHO DA, ROSNER G, EGORIN MJ, BUDMAN DR, VOGELZANG NJ, NORTON L, SCHILSKI RL: Phase-I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks - A Cancer and Leukemia Group-B Study. J Nat Cancer Inst 85: 1319-1326, 1993.
8. MULLER H, NAKCHBANDI V, CHATZISAVVIDIS I, VON VOIGT C: Repetitive chemoembolization with melphalan plus intra-arterial immunochemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first and second-line treatment of disseminated colorectal liver metastases. Hepato-gastroenterology 50: 1919-1926, 2003.
9. NAGATA S: Granulocyte colony-stimulating factor and its receptor. In: The Cytokine Handbook, THOMSON AW (ed.) Academic Press, London, 1994, pp 371-386.
10. NETA R, OPPENHEIM JJ, DOUCHES SD: Interdependence of the radioprotective effects of human recombinant interleukin 1-alpha, tumor necrosis factor-alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J Immunol 140: 108-111, 1988.
11. NICOLA NA, BEGLEY CG, METCALF D: Identification of the human analog of a regulator that induces differentiation in murine leukemic cells. Nature 314: 625-628, 1985.
12. OH WK, HALABI S, KELLY WK, WERNER C, GODLEY PA, VOGELZANG NJ, SMALL EJ: A phase II study of estramustine, docetaxel, and carboplatin with granulocyte colony-stimulating factor support in patients with hormone-refractory prostate carcinoma - Cancer and Leukemia Group B 99813. Cancer 98: 2592-2598, 2003.
13. PATCHEN ML, FISCHER R, MACVITTIE TJ, SEILER FR, WILLIAMS DE: Mast-cell growth-factor (cKit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3 - in-vivo hematopoietic effects in irradiated mice compared to in vitro effects. Biotherapy 7: 13-26, 1993.
14. POSPÍŠIL M, HOFER M, VACEK A, ZNOJIL V, PIPALOVA I: Effects of stable adenosine receptor agonists on bone marrow hematopoietic cells as inferred from the cytoxic action of 5-fluorouracil. Physiol Res 53: 549-556, 2004.
15. RASKO JEJ, GOUGH NM: Granulocyte-macrophage colony-stimulating factor. In: The Cytokine Handbook. THOMSON AW (ed), Academic Press, London, 1994, pp 343-370.
16. VACEK A, BARTONÍČKOVÁ A, ROTKOVSKÁ D: Radioprotection of hematopoiesis conferred by aqueous extract from chlorococcal algaye (IVASTIMUL) administered to mice before irradiation. Exp. Hematol 183: 234-237, 1990.
17. VACEK A, HOFER M, MAŠEK K: Effects of in vivo administration of adamantylamide dipeptide on bone marrow granulocyte-macrophage hemopoietic progenitor cells (GM-CFC) and on ability of serum of the treated mice to stimulate GM-CFC colony formation in vitro: comparison with muramyl dipeptide and glucan. Immunopharmacol Immunotoxicol 21: 1-14, 1999.
18. VACEK A, HOFER M, BARNET K, ČECH K, PEKÁREK J, SCHNEIDEROVÁ H: Positive effects of dialyzable leukocyte extract (DLE) on recovery of mouse hemopoiesis suppressed by ionizing radiation and on proliferation of hemopoietic progenitor cells in vitro. Int J Immunopharmacol 22: 623-634, 2000.
19. VACEK A, HOFER M, WEITEROVÁ L, HOFEROVÁ Z, PIPALOVÁ I, MAŠEK K: Hemopoiesis-stimulating action of adamantylamide dipeptide: kinetics of increase of GM-CFC in femur and co-stimulating activity of serum, role of bone marrow cells. Immunopharmacol Immunotoxicol 23: 505-517, 2001.
20. VACEK A, HOFER M, HROMAS J, LUKŠÍKOVÁ E, SVOBODA J, SCHNEIDEROVÁ H: Hemopoiesis-stimulating effects and enhanced survival of irradiated mice after peroral or intraperitoneal administration of ultrafiltered pig leukocyte extract (UPLE, IMUNOR®). Immunopharmacol Immunotoxicol 24: 651-664, 2002.
21. VIRCHIS A, KOH M, RANKIN P, MEHTA A, POTTER M, HOFFBRAND AV, PRENTICE HG: Fludarabine, cytosine arabinoside, granulocyte colony-stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. Br J Hematol 124: 26-32, 2004.
22. WATARI K, OZAWA K, TAKAHASHI S, TOJO A, TANI K, KAMACHI S, ASANO S: Pharmacokinetic studies of intravenous glycosylated recombinant human granulocyte colony-stimulating factor in various hematological disorders: inverse correlation between the half-life and bone marrow myeloid cell pool. Int J Hematol 66: 57-67, 1997.
23. WELTE K, GABRILOVE J, BRONCHUD MH, PLATZER E, MORSTYN G: Filgrastim (r-metHuG-CSF): te first 10 years. Blood 88: 1907-1929, 1996.
24. WU HH, TALPAZ M, CHAMPLIN RE, PILAT SR, KURZROCK R: Sequential interleukin 3 and granulocyte-macrophage colony-stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses. Cancer 98: 2410-2419, 2003.